PDB Short entry for 3DK7 HEADER TRANSFERASE 24-JUN-08 3DK7 TITLE CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX WITH SMALL TITLE 2 MOLECULE FRAGMENT COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1, C-ABL, COMPND 5 P150; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: ABL1, ABL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI KEYWDS DRUG DISCOVERY, ABL KINASE, FRAGMENT BASED, ALTERNATIVE SPLICING, KEYWDS 2 ATP-BINDING, CELL ADHESION, CHROMOSOMAL REARRANGEMENT, CYTOPLASM, KEYWDS 3 CYTOSKELETON, KINASE, LIPOPROTEIN, MAGNESIUM, MANGANESE, METAL- KEYWDS 4 BINDING, MYRISTATE, NUCLEOTIDE-BINDING, NUCLEUS, PHOSPHOPROTEIN, KEYWDS 5 PROTO-ONCOGENE, SH2 DOMAIN, SH3 DOMAIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR H.A.LEWIS REVDAT 3 20-OCT-21 3DK7 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 3DK7 1 VERSN REVDAT 1 29-JUL-08 3DK7 0 JRNL AUTH P.-Y.BOUNAUD,A.GOSBERG,J.HENDLE,H.A.LEWIS,R.ROMERO, JRNL AUTH 2 M.E.WILSON,F.ZHANG JRNL TITL CRYSTAL STRUCTURE OF MUTANT ABL KINASE DOMAIN IN COMPLEX JRNL TITL 2 WITH SMALL MOLECULE FRAGMENT JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.01 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.01 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 53692 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4214 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 283 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3DK7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-JUN-08. REMARK 100 THE DEPOSITION ID IS D_1000048140. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-MAR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97969 REMARK 200 MONOCHROMATOR : DIAMOND REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALA 3.2.5 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53692 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.010 REMARK 200 RESOLUTION RANGE LOW (A) : 28.118 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : 0.24600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 2.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.9M AMMONIUM SULFATE, 150 MM REMARK 280 POTASSIUM SODIUM TARTRATE, 100 MM SODIUM CITRATE, PH 5.6, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 52.97050 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 66.35600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 52.97050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 66.35600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 230 REMARK 465 SER A 231 REMARK 465 LEU A 232 REMARK 465 GLU A 275 REMARK 465 ASP A 276 REMARK 465 THR A 277 REMARK 465 MET A 278 REMARK 465 SER A 503 REMARK 465 ASP A 504 REMARK 465 GLU A 505 REMARK 465 GLY A 506 REMARK 465 GLY B 230 REMARK 465 SER B 231 REMARK 465 LEU B 232 REMARK 465 LYS B 274 REMARK 465 GLU B 275 REMARK 465 ASP B 276 REMARK 465 THR B 277 REMARK 465 GLY B 506 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 234 CG CD CE NZ REMARK 470 LYS A 245 NZ REMARK 470 HIS A 246 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 274 CG CD CE NZ REMARK 470 LYS A 294 CG CD CE NZ REMARK 470 ARG A 307 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 308 CG CD OE1 OE2 REMARK 470 LYS A 467 CG CD CE NZ REMARK 470 GLN A 498 CG CD OE1 NE2 REMARK 470 ILE A 502 CG1 CG2 CD1 REMARK 470 ASP B 233 CG OD1 OD2 REMARK 470 LYS B 234 CG CD CE NZ REMARK 470 GLU B 238 CG CD OE1 OE2 REMARK 470 ARG B 239 CG CD NE CZ NH1 NH2 REMARK 470 THR B 240 OG1 CG2 REMARK 470 THR B 243 OG1 CG2 REMARK 470 LYS B 245 CD CE NZ REMARK 470 HIS B 246 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 247 CD CE NZ REMARK 470 LYS B 262 CG CD CE NZ REMARK 470 LYS B 263 CG CD CE NZ REMARK 470 TYR B 264 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 271 CG CD CE NZ REMARK 470 GLU B 279 CG CD OE1 OE2 REMARK 470 GLU B 281 CG CD OE1 OE2 REMARK 470 GLU B 282 CD OE1 OE2 REMARK 470 LEU B 284 CD1 CD2 REMARK 470 LYS B 285 CG CD CE NZ REMARK 470 GLU B 286 CD OE1 OE2 REMARK 470 GLU B 292 CG CD OE1 OE2 REMARK 470 LYS B 294 CG CD CE NZ REMARK 470 ARG B 307 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 308 CG CD OE1 OE2 REMARK 470 ASN B 374 OD1 ND2 REMARK 470 PHE B 382 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 400 CG CD CE NZ REMARK 470 GLU B 505 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 245 -140.09 -113.81 REMARK 500 ARG A 362 -1.99 79.79 REMARK 500 ASP A 363 47.78 -147.51 REMARK 500 PRO A 402 90.62 -69.74 REMARK 500 LYS B 245 -145.95 -120.89 REMARK 500 GLU B 279 46.79 -82.19 REMARK 500 THR B 306 73.26 -115.08 REMARK 500 ARG B 307 -46.75 -143.16 REMARK 500 ARG B 362 -1.22 75.78 REMARK 500 ASP B 363 45.03 -144.45 REMARK 500 ASP B 381 30.92 -99.10 REMARK 500 PHE B 382 -78.64 -47.67 REMARK 500 PRO B 402 99.33 -64.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 3 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SX7 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SX7 B 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3DK3 RELATED DB: PDB REMARK 900 RELATED ID: 3DK6 RELATED DB: PDB DBREF 3DK7 A 233 505 UNP P00520 ABL1_MOUSE 233 505 DBREF 3DK7 B 233 505 UNP P00520 ABL1_MOUSE 233 505 SEQADV 3DK7 GLY A 230 UNP P00520 EXPRESSION TAG SEQADV 3DK7 SER A 231 UNP P00520 EXPRESSION TAG SEQADV 3DK7 LEU A 232 UNP P00520 EXPRESSION TAG SEQADV 3DK7 ILE A 315 UNP P00520 THR 315 ENGINEERED MUTATION SEQADV 3DK7 PRO A 445 UNP P00520 LEU 445 ENGINEERED MUTATION SEQADV 3DK7 GLY A 506 UNP P00520 EXPRESSION TAG SEQADV 3DK7 GLY B 230 UNP P00520 EXPRESSION TAG SEQADV 3DK7 SER B 231 UNP P00520 EXPRESSION TAG SEQADV 3DK7 LEU B 232 UNP P00520 EXPRESSION TAG SEQADV 3DK7 ILE B 315 UNP P00520 THR 315 ENGINEERED MUTATION SEQADV 3DK7 PRO B 445 UNP P00520 LEU 445 ENGINEERED MUTATION SEQADV 3DK7 GLY B 506 UNP P00520 EXPRESSION TAG SEQRES 1 A 277 GLY SER LEU ASP LYS TRP GLU MET GLU ARG THR ASP ILE SEQRES 2 A 277 THR MET LYS HIS LYS LEU GLY GLY GLY GLN TYR GLY GLU SEQRES 3 A 277 VAL TYR GLU GLY VAL TRP LYS LYS TYR SER LEU THR VAL SEQRES 4 A 277 ALA VAL LYS THR LEU LYS GLU ASP THR MET GLU VAL GLU SEQRES 5 A 277 GLU PHE LEU LYS GLU ALA ALA VAL MET LYS GLU ILE LYS SEQRES 6 A 277 HIS PRO ASN LEU VAL GLN LEU LEU GLY VAL CYS THR ARG SEQRES 7 A 277 GLU PRO PRO PHE TYR ILE ILE ILE GLU PHE MET THR TYR SEQRES 8 A 277 GLY ASN LEU LEU ASP TYR LEU ARG GLU CYS ASN ARG GLN SEQRES 9 A 277 GLU VAL SER ALA VAL VAL LEU LEU TYR MET ALA THR GLN SEQRES 10 A 277 ILE SER SER ALA MET GLU TYR LEU GLU LYS LYS ASN PHE SEQRES 11 A 277 ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS LEU VAL GLY SEQRES 12 A 277 GLU ASN HIS LEU VAL LYS VAL ALA ASP PHE GLY LEU SER SEQRES 13 A 277 ARG LEU MET THR GLY ASP THR PTR THR ALA HIS ALA GLY SEQRES 14 A 277 ALA LYS PHE PRO ILE LYS TRP THR ALA PRO GLU SER LEU SEQRES 15 A 277 ALA TYR ASN LYS PHE SER ILE LYS SER ASP VAL TRP ALA SEQRES 16 A 277 PHE GLY VAL LEU LEU TRP GLU ILE ALA THR TYR GLY MET SEQRES 17 A 277 SER PRO TYR PRO GLY ILE ASP PRO SER GLN VAL TYR GLU SEQRES 18 A 277 LEU LEU GLU LYS ASP TYR ARG MET GLU ARG PRO GLU GLY SEQRES 19 A 277 CYS PRO GLU LYS VAL TYR GLU LEU MET ARG ALA CYS TRP SEQRES 20 A 277 GLN TRP ASN PRO SER ASP ARG PRO SER PHE ALA GLU ILE SEQRES 21 A 277 HIS GLN ALA PHE GLU THR MET PHE GLN GLU SER SER ILE SEQRES 22 A 277 SER ASP GLU GLY SEQRES 1 B 277 GLY SER LEU ASP LYS TRP GLU MET GLU ARG THR ASP ILE SEQRES 2 B 277 THR MET LYS HIS LYS LEU GLY GLY GLY GLN TYR GLY GLU SEQRES 3 B 277 VAL TYR GLU GLY VAL TRP LYS LYS TYR SER LEU THR VAL SEQRES 4 B 277 ALA VAL LYS THR LEU LYS GLU ASP THR MET GLU VAL GLU SEQRES 5 B 277 GLU PHE LEU LYS GLU ALA ALA VAL MET LYS GLU ILE LYS SEQRES 6 B 277 HIS PRO ASN LEU VAL GLN LEU LEU GLY VAL CYS THR ARG SEQRES 7 B 277 GLU PRO PRO PHE TYR ILE ILE ILE GLU PHE MET THR TYR SEQRES 8 B 277 GLY ASN LEU LEU ASP TYR LEU ARG GLU CYS ASN ARG GLN SEQRES 9 B 277 GLU VAL SER ALA VAL VAL LEU LEU TYR MET ALA THR GLN SEQRES 10 B 277 ILE SER SER ALA MET GLU TYR LEU GLU LYS LYS ASN PHE SEQRES 11 B 277 ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS LEU VAL GLY SEQRES 12 B 277 GLU ASN HIS LEU VAL LYS VAL ALA ASP PHE GLY LEU SER SEQRES 13 B 277 ARG LEU MET THR GLY ASP THR PTR THR ALA HIS ALA GLY SEQRES 14 B 277 ALA LYS PHE PRO ILE LYS TRP THR ALA PRO GLU SER LEU SEQRES 15 B 277 ALA TYR ASN LYS PHE SER ILE LYS SER ASP VAL TRP ALA SEQRES 16 B 277 PHE GLY VAL LEU LEU TRP GLU ILE ALA THR TYR GLY MET SEQRES 17 B 277 SER PRO TYR PRO GLY ILE ASP PRO SER GLN VAL TYR GLU SEQRES 18 B 277 LEU LEU GLU LYS ASP TYR ARG MET GLU ARG PRO GLU GLY SEQRES 19 B 277 CYS PRO GLU LYS VAL TYR GLU LEU MET ARG ALA CYS TRP SEQRES 20 B 277 GLN TRP ASN PRO SER ASP ARG PRO SER PHE ALA GLU ILE SEQRES 21 B 277 HIS GLN ALA PHE GLU THR MET PHE GLN GLU SER SER ILE SEQRES 22 B 277 SER ASP GLU GLY MODRES 3DK7 PTR A 393 TYR O-PHOSPHOTYROSINE MODRES 3DK7 PTR B 393 TYR O-PHOSPHOTYROSINE HET PTR A 393 16 HET PTR B 393 16 HET SX7 A 1 28 HET SO4 B 3 5 HET SO4 B 4 5 HET SX7 B 2 28 HETNAM PTR O-PHOSPHOTYROSINE HETNAM SX7 2-AMINO-5-[3-(1-ETHYL-1H-PYRAZOL-5-YL)-1H-PYRROLO[2,3- HETNAM 2 SX7 B]PYRIDIN-5-YL]-N,N-DIMETHYLBENZAMIDE HETNAM SO4 SULFATE ION HETSYN PTR PHOSPHONOTYROSINE HETSYN SX7 2-AMINO-5-[3-(2-ETHYL-2H-PYRAZOL-3-YL)-1H-PYRROLO[2,3- HETSYN 2 SX7 B]PYRIDIN-5-YL]-N,N-DIMETHYL-BENZAMIDE FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 3 SX7 2(C21 H22 N6 O) FORMUL 4 SO4 2(O4 S 2-) FORMUL 7 HOH *283(H2 O) HELIX 1 1 GLU A 238 THR A 240 5 3 HELIX 2 2 GLY A 249 GLN A 252 5 4 HELIX 3 3 LYS A 263 SER A 265 5 3 HELIX 4 4 GLU A 279 LYS A 291 1 13 HELIX 5 5 ASN A 322 CYS A 330 1 9 HELIX 6 6 SER A 336 LYS A 357 1 22 HELIX 7 7 ALA A 365 ARG A 367 5 3 HELIX 8 8 GLU A 373 HIS A 375 5 3 HELIX 9 9 PRO A 402 THR A 406 5 5 HELIX 10 10 ALA A 407 ASN A 414 1 8 HELIX 11 11 SER A 417 THR A 434 1 18 HELIX 12 12 ASP A 444 SER A 446 5 3 HELIX 13 13 GLN A 447 LYS A 454 1 8 HELIX 14 14 PRO A 465 TRP A 476 1 12 HELIX 15 15 ASN A 479 ARG A 483 5 5 HELIX 16 16 SER A 485 ILE A 502 1 18 HELIX 17 17 GLU B 238 THR B 240 5 3 HELIX 18 18 GLU B 279 ILE B 293 1 15 HELIX 19 19 ASN B 322 CYS B 330 1 9 HELIX 20 20 SER B 336 LYS B 357 1 22 HELIX 21 21 ALA B 365 ARG B 367 5 3 HELIX 22 22 GLU B 373 HIS B 375 5 3 HELIX 23 23 PRO B 402 THR B 406 5 5 HELIX 24 24 ALA B 407 ASN B 414 1 8 HELIX 25 25 SER B 417 THR B 434 1 18 HELIX 26 26 ASP B 444 SER B 446 5 3 HELIX 27 27 GLN B 447 LYS B 454 1 8 HELIX 28 28 PRO B 465 TRP B 476 1 12 HELIX 29 29 ASN B 479 ARG B 483 5 5 HELIX 30 30 SER B 485 SER B 500 1 16 SHEET 1 A 5 ILE A 242 LYS A 247 0 SHEET 2 A 5 VAL A 256 TRP A 261 -1 O GLU A 258 N HIS A 246 SHEET 3 A 5 LEU A 266 THR A 272 -1 O LEU A 266 N TRP A 261 SHEET 4 A 5 TYR A 312 GLU A 316 -1 O ILE A 315 N ALA A 269 SHEET 5 A 5 LEU A 301 CYS A 305 -1 N LEU A 302 O ILE A 314 SHEET 1 B 2 PHE A 359 ILE A 360 0 SHEET 2 B 2 SER A 385 ARG A 386 -1 O SER A 385 N ILE A 360 SHEET 1 C 2 CYS A 369 VAL A 371 0 SHEET 2 C 2 VAL A 377 VAL A 379 -1 O LYS A 378 N LEU A 370 SHEET 1 D 2 PTR A 393 THR A 394 0 SHEET 2 D 2 LYS A 415 PHE A 416 -1 O PHE A 416 N PTR A 393 SHEET 1 E 5 ILE B 242 LYS B 247 0 SHEET 2 E 5 VAL B 256 TRP B 261 -1 O VAL B 260 N THR B 243 SHEET 3 E 5 LEU B 266 THR B 272 -1 O LEU B 266 N TRP B 261 SHEET 4 E 5 TYR B 312 GLU B 316 -1 O ILE B 315 N ALA B 269 SHEET 5 E 5 LEU B 301 CYS B 305 -1 N LEU B 302 O ILE B 314 SHEET 1 F 2 PHE B 359 ILE B 360 0 SHEET 2 F 2 SER B 385 ARG B 386 -1 O SER B 385 N ILE B 360 SHEET 1 G 2 CYS B 369 VAL B 371 0 SHEET 2 G 2 VAL B 377 VAL B 379 -1 O LYS B 378 N LEU B 370 SHEET 1 H 2 PTR B 393 THR B 394 0 SHEET 2 H 2 LYS B 415 PHE B 416 -1 O PHE B 416 N PTR B 393 LINK C THR A 392 N PTR A 393 1555 1555 1.33 LINK C PTR A 393 N THR A 394 1555 1555 1.33 LINK C THR B 392 N PTR B 393 1555 1555 1.33 LINK C PTR B 393 N THR B 394 1555 1555 1.33 CISPEP 1 PRO A 309 PRO A 310 0 -1.16 CISPEP 2 PRO B 309 PRO B 310 0 0.37 SITE 1 AC1 3 ARG B 362 ALA B 395 HIS B 396 SITE 1 AC2 3 ARG B 460 GLU B 462 GLY B 463 SITE 1 AC3 15 LEU A 248 GLY A 249 TYR A 253 ALA A 269 SITE 2 AC3 15 ILE A 315 GLU A 316 PHE A 317 MET A 318 SITE 3 AC3 15 THR A 319 GLY A 321 ASN A 322 LEU A 370 SITE 4 AC3 15 ALA A 380 ASP A 381 PHE A 382 SITE 1 AC4 13 LEU B 248 GLY B 249 TYR B 253 ALA B 269 SITE 2 AC4 13 ILE B 315 GLU B 316 PHE B 317 MET B 318 SITE 3 AC4 13 THR B 319 GLY B 321 ASN B 322 LEU B 370 SITE 4 AC4 13 ALA B 380 CRYST1 105.941 132.712 56.297 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009439 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007535 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017763 0.00000